Case number 1:21-cv-01742
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 1, 2023 | 122 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc.; Corporate Parent Viatris Inc. for Mylan Inc. filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 02/01/2023) (2) |
| Jan 18, 2023 | 121 | ORAL ORDER: For the reasons stated on the record on January 18, 2023, a stay of the case is GRANTED until fourteen days after the PTAB issues a final written decision on the related IPR. At that time, the parties are to submit a joint status report with a proposed schedule resulting in a trial date in January or February 2024. The motion to extend schedule (D.I. 125) is DISMISSED as moot. Ordered by Judge Richard G. Andrews on 1/18/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 01/18/2023) (0) |
| Jan 6, 2023 | 120 | ORAL ORDER: A hearing on the Motion to Extend Schedule (D.I. 134 in 21-cv-314-RGA-JLH; D.I. 113 in 21-cv-1742-RGA; D.I. 125 in 21-md-3017-RGA) is now set for 1/18/2023, at 10:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 1/6/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 01/06/2023) (0) |
| Jan 3, 2023 | 119 | Letter to The Honorable Richard G. Andrews, from Emily S. DiBenedetto, regarding request for oral argument. (DiBenedetto, Emily) Modified on 1/4/2023 (nms). (Entered: 01/03/2023) (1) |
| Dec 16, 2022 | 118 | ANSWERING BRIEF in Opposition re 113 MOTION to Extend Schedule, filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..Reply Brief due date per Local Rules is 12/27/2022. (Fahnestock, Derek) Modified on 12/16/2022 (nms). (Entered: 12/16/2022) (13) |
| Dec 13, 2022 | 116 | STIPULATION and [Proposed] Order to Extend Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 12/13/2022) (4) |
| Dec 13, 2022 | 117 | STIPULATION and Proposed Order to Extend Time to file their response to Defendants' Motion to Extend Schedule - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/13/2022 (nms). (Entered: 12/13/2022) (3) |
| Dec 2, 2022 | 115 | NOTICE OF SERVICE of (1) Plaintiff Bayer's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) and (2) Plaintiff Janssen's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 12/02/2022) (9) |
| Dec 1, 2022 | 114 | MOTION for Pro Hac Vice Appearance of Attorney Susannah M. L. Gagnon of Wilson Sonsini Goodrich and Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 12/01/2022) (3) |
| Nov 29, 2022 | 113 | MOTION to Extend Schedule - filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 11/29/2022 (nms). (Entered: 11/29/2022) (6) |
| Nov 7, 2022 | 111 | STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants Mylan Pharmaceutical Inc. and Mylan Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 11/07/2022) (3) |
| Nov 7, 2022 | 112 | SO ORDERED Granting 111 Stipulation and [Proposed] Order Regarding Infringement (as to Defendants Mylan Pharmaceutical Inc. and Mylan Inc.). Signed by Judge Richard G. Andrews on 11/7/2022. (nms) (Entered: 11/07/2022) (3) |
| Nov 2, 2022 | 107 | NOTICE to Take Deposition of Nancy Cook Bruns filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022) (4) |
| Nov 2, 2022 | 108 | NOTICE to Take Deposition of Frank Misselwitz filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022) (4) |
| Nov 2, 2022 | 109 | NOTICE to Take Deposition of Bayer Pharma AG and Bayer AG filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022) (10) |
| Nov 2, 2022 | 110 | NOTICE to Take Deposition of Janssen Pharmaceuticals, Inc. filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022) (10) |
| Oct 18, 2022 | 106 | SO ORDERED Granting (D.I. 107 in 21-md-3017-RGA; D.I. 39 in 22-cv-1228-RGA; D.I. 104 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order Consolidating Cases and Adopting Schedule. Signed by Judge Richard G. Andrews on 10/18/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA, 1:22-cv-01228-RGA(nms) (Entered: 10/18/2022) (3) |
| Oct 17, 2022 | 104 | Joint Stipulation and [Proposed] Order Consolidating Cases and Adopting Schedule, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 10/18/2022 (nms). (Entered: 10/17/2022) (3) |
| Oct 17, 2022 | 105 | NOTICE OF SERVICE of Defendants' Prior Art Narrowing Disclosure (also filed on behalf of Defendant Teva Pharmaceuticals USA, Inc.) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 10/17/2022) (2) |
| Sep 30, 2022 | 103 | Joint Stipulation and [Proposed] Order to Extend Time, by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 9/30/2022 (nms). (Entered: 09/30/2022) (4) |
| Sep 19, 2022 | 100 | NOTICE to Take Deposition of Beth Britton on October 6, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 101 | NOTICE to Take Deposition of Kristen McElwayne on October 13, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 19, 2022 | 102 | NOTICE to Take Deposition of Wayne Talton on October 14, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022) (3) |
| Sep 12, 2022 | 99 | NOTICE OF SERVICE of Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Mylan Pharmaceuticals Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 09/12/2022) (3) |
| Sep 9, 2022 | 98 | MOTION for Pro Hac Vice Appearance of Attorney Seth R. Bowers - filed by Bayer AG, Bayer Pharma AG. (Fahnestock, Derek) (Entered: 09/09/2022) (8) |
| Sep 8, 2022 | 97 | STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 09/08/2022) (3) |
| Sep 7, 2022 | 96 | NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. and Mylan Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 09/07/2022) (8) |
| Aug 24, 2022 | 94 | STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 9, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 08/24/2022) (3) |
| Aug 24, 2022 | 95 | SO ORDERED, re (D.I. 94 in 21-cv-1742-RGA; D.I. 70 in 21-md-3017-RGA; 94 in 21-cv-314-RGA-JLH) STIPULATION to Extend Time for Plaintiffs and Defendants to substantially complete document production to September 9, 2022. Signed by Judge Richard G. Andrews on 8/24/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 08/24/2022) (0) |
| Jul 27, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 68 in 21-md-3017-RGA; D.I. 92 in 21-cv-314-RGA-JLH; D.I.93 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 7/27/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| Jul 26, 2022 | 93 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production shall be extended from August 5, 2022 to allow the parties additional time to search for and produce documents to August 26, 2022 - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) |
| Jun 7, 2022 | 92 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. And Mylan Inc.'s Objections And Responses To Plaintiffs' First Joint Set Of Interrogatories (Nos. 1-7), and Mylan Pharmaceuticals Inc. And Mylan Inc.'s Objections And Responses To Plaintiffs' First Set Of Requests For Production (Nos. 1-43) filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) |
| Jun 1, 2022 | 91 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); (2) Plaintiffs Bayer Pharma AG and Bayer AG's Responses to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9); (3) Plaintiff Janssen Pharmaceutical Inc.'s Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); and (4) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| May 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 71 in 21-cv-314-RGA-JLH; D.I. 47 in 21-md-3017-RGA; D.I. 88 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time to Submit Joint Claim Construction Chart to May 24, 2022. Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| May 24, 2022 | 89 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order regarding claim construction, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/24/2022 (nms). |
| May 24, 2022 | N/A | Order (0) Docket Text: SO ORDERED Granting (D.I. 89 in 21-cv-1742-RGA; D.I. 72 in 21-cv-314-RGA-JLH; D.I. 48 in 21-md-3017-RGA) Stipulation and Proposed Order regarding claim construction (*The Markman hearing scheduled for 8/23/2022 is CANCELED). Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| May 23, 2022 | 88 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Chart to May 24, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Haney, Megan) |
| May 20, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 45 in 21-md-3017-RGA; D.I. 69 in 21-cv-314-RGA-JLH; D.I. 87 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022. Signed by Judge Richard G. Andrews on 5/20/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| May 19, 2022 | 87 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| May 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 85 in 21-cv-1742-RGA; D.I. 68 in 21-cv-314-RGA-JLH; D.I. 43 in 21-md-3017-RGA) STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) |
| May 18, 2022 | 86 | Order (2) Docket Text: SO ORDERED Granting (D.I. 84 in 21-cv-1742-RGA; D.I. 42 in 21-md-3017-RGA) Stipulation Amending Order. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) |
| May 17, 2022 | 84 | Stipulation (2) Docket Text: STIPULATION Amending Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms). |
| May 17, 2022 | 85 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms). |
| May 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 83 in 21-cv-1742-RGA; D.I. 41 in 21-md-3017-RGA; D.I. 67 in 21-cv-314-RGA-JLH) STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) |
| May 13, 2022 | 83 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| May 2, 2022 | 82 | Notice (Other) (6) Docket Text: NOTICE of Change of Address for Williams & Connolly LLP by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc. (Fahnestock, Derek) |
| Apr 29, 2022 | 81 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Claim Construction Issue Identification - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Apr 22, 2022 | 80 | Notice of Service (13) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Joint Set of Interrogatories to Defendants, (2) Plaintiffs' First Set of Requests for Production to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., (3) Plaintiffs' First Set of Requests for Production to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc., (4) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (5) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (6) Plaintiffs' First Set of Requests for Production to Defendants Micro Labs Ltd. and Micro Labs USA, Inc., and (7) Plaintiffs' First Set of Requests for Production to Defendants Mylan Pharmaceuticals, Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Jan 31, 2022 | 77 | Main Document (2) Docket Text: PROPOSED Order Adopting Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Fahnestock, Derek) Modified on 1/31/2022 (nms). |
| Jan 31, 2022 | 77 | Letter to The Honorable Richard G. Andrews (1) |
| Jan 31, 2022 | 78 | Order (2) Docket Text: ORDER ADOPTING SCHEDULE: The 314 Scheduling Order shall govern in this Action as if entered in this action, except that paragraphs 14-16 pertaining to the pretrial and trial shall not be applicable. Signed by Judge Richard G. Andrews on 1/31/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms) |
| Jan 31, 2022 | 79 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) |
| Jan 28, 2022 | 76 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Mylan's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Jan 25, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties are requested to jointly submit a proposed order formally adopting the schedule already in place for related consolidated civil action 21-314-RGA. The proposed order is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 1/25/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms) |
| Jan 18, 2022 | 74 | Letter (1) Docket Text: Joint Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding status. (Fahnestock, Derek) Modified on 1/18/2022 (nms). |
| Jan 12, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A joint status letter is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 1/12/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms) |
| Dec 29, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Ty W. Callahan, Wendy L. Devine, and Elham F. Steiner for Mylan Inc. and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Dec 29, 2021 | 70 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Bayer AG, Bayer Pharma AG.(Fahnestock, Derek) |
| Dec 29, 2021 | 71 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) |
| Dec 29, 2021 | 72 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. And Mylan Inc.'s Disclosures Pursuant To Paragraph 3 Of The Delaware Default Standard Of Discovery; and Mylan Pharmaceuticals Inc. And Mylan Inc.'s Production Of Core Technical Documents Pursuant To Paragraph 4(b) Of Delawares Default Standard For Discovery [CONFIDENTIAL] filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Moore, David) |
| Dec 28, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 5 in 21-md-3017-RGA,; D.I. 69 in 21-cv-1742-RGA) MOTION for Pro Hac Vice Appearance of Attorney Wendy Devine, Elham F. Steiner, and Ty W. Callahan of Wilson Sonsini Goodrich and Rosati, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/28/2021. Associated Cases: 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) |
| Dec 28, 2021 | 69 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wendy Devine, Elham F. Steiner, and Ty W. Callahan of Wilson Sonsini Goodrich and Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) |
| Dec 15, 2021 | N/A | Remark - MDL Notice to Counsel (0) Docket Text: NOTICE TO COUNSEL: MDL No. 1:21-md-3017 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents and are not registered, should register for E-filing rights through PACER. Please see the docket for further entries. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 15, 2021 | N/A | Remark - MDL Member (0) Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 15, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Dec 15, 2021 | 68 | Order (4) Docket Text: CERTIFIED TRANSFER ORDER - issued by the Panel on the Multi-District Litigation on 12/10/2021. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 14, 2021 | 67 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Derek James Fahnestock on behalf of Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc. (Fahnestock, Derek) |
| Dec 13, 2021 | 65 | Main Document Public Docket Sheet (15) Docket Text: Record of case transferred in from District of West Virginia Northern; Case Number in Other District: 1:21-cv-00099. Copy of Docket Sheet and original file |
| Dec 13, 2021 | 65 | *Restricted* (15) |
| Dec 13, 2021 | 66 | Letter (2) Docket Text: Local Counsel Letter sent. Notice of Compliance deadline set for 1/12/2022. (nmg) |
| Dec 10, 2021 | N/A | Case Transferred Out to Another District (0) Docket Text: Case transferred to District of Delaware re MDL 3017. Entire Case file electronically transmitted. (cnd) [Transferred from West Virginia Northern on 12/13/2021.] |
| Dec 10, 2021 | 64 | Order (4) Docket Text: CERTIFIED Copy of JPML Transfer Order re: pldg (MDL No. 3017) Transferring 1 action(s) to Judge Richard G. Andrews in the D. Delaware. Signed by Judge Karen K. Caldwell, Chair, Panel on Multidistrict Litigation on 12/10/2021. [Transferred from West Virginia Northern on 12/13/2021.] Modified on 12/15/2021 (nms). |
| Nov 30, 2021 | 63 | Main Document (3) Docket Text: STATUS Report Regarding Plaintiffs' Proposed Trial Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit)(Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] Modified on 12/14/2021 (nms). |
| Nov 30, 2021 | 63 | Exhibit (3) |
| Nov 15, 2021 | 62 | Answer to Counterclaim (8) Docket Text: ANSWER to [53] Amended Answer to Complaint, Counterclaim by Bayer AG, Janssen Pharmaceuticals, Inc..(Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Nov 12, 2021 | 59 | Main Document (6) Docket Text: Courtesy Copy of Documents filed with the JPML. (Attachments: # (1) Notice of Presentment or Waiver of Oral Argument, # (2) Envelope) (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Nov 12, 2021 | 59 | Notice of Presentment or Waiver of Oral Argument (2) |
| Nov 12, 2021 | 59 | Envelope (1) |
| Nov 12, 2021 | 60 | Main Document (7) Docket Text: MEMORANDUM in Support of Sept. 2023 Trial Date by Bayer Pharma AG, Janssen Pharmaceuticals, Inc. . (Attachments: # (1) Exhibit Exhibit A, # (2) Exhibit Exhibit B, # (3) Exhibit Exhibit C)(Taylor, Chad)[Transferred from West Virginia Northern on 12/13/2021.] |
| Nov 12, 2021 | 60 | Exhibit Exhibit A (14) |
| Nov 12, 2021 | 60 | Exhibit Exhibit B (5) |
| Nov 12, 2021 | 60 | Exhibit Exhibit C (16) |
| Nov 12, 2021 | 61 | Main Document (5) Docket Text: Brief Regarding Proposed Trial Date, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D)(O'Brien, William)[Transferred from West Virginia Northern on 12/13/2021.] Modified on 12/15/2021 (nms). |
| Nov 12, 2021 | 61 | Exhibit A (9) |
| Nov 12, 2021 | 61 | Exhibit B (13) |
| Nov 12, 2021 | 61 | Exhibit C (3) |
| Nov 12, 2021 | 61 | Exhibit D (14) |
| Nov 8, 2021 | 58 | Appeal Transcript Request (2) Docket Text: TRANSCRIPT PURCHASE ORDER by Mylan Inc. for proceedings held on 11/1/2021 before Judge Kleeh. (ck) [Transferred from West Virginia Northern on 12/13/2021.] |
| Nov 5, 2021 | 56 | Transcript (15) Docket Text: TRANSCRIPT of status conference held on 11/1/2021, before Judge Kleeh. Court Reporter/Transcriber Cindy Knecht, Telephone number 304.234.3968. Parties have five business days to file a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript will become available via PACER to the public without redaction after 90 calendar days.. Redaction Request due 11/26/2021. Redacted Transcript Deadline set for 12/6/2021. Release of Transcript Restriction set for 2/3/2022. (ck) [Transferred from West Virginia Northern on 12/13/2021.] |
| Nov 5, 2021 | 57 | Appeal Transcript Request (2) Docket Text: TRANSCRIPT PURCHASE ORDER by Bayer AG for proceedings held on 11/1/2021 before Judge Kleeh. (ck) [Transferred from West Virginia Northern on 12/13/2021.] |
| Nov 1, 2021 | 53 | Amended Answer to Complaint (20) Docket Text: AMENDED ANSWER to [1] Complaint , COUNTERCLAIM against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. by Mylan Inc., Mylan Pharmaceuticals Inc.. (O'Brien, William)[Transferred from West Virginia Northern on 12/13/2021.] |
| Nov 1, 2021 | 55 | Order (1) Docket Text:ORDER DIRECTING BRIEFS: The Court ORDERS the parties to submit briefs on or before Friday, November 12, 2021. Signed by District Judge Thomas S. Kleeh on 11/1/21. (jss) [Transferred from West Virginia Northern on 12/13/2021.] |
| Oct 20, 2021 | 51 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting [49] Motion of Ty W. Callahan for Leave to Appear Pro Hac Vice on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. Signed by District Judge Thomas S. Kleeh on 10/20/2021. (dk)[Transferred from West Virginia Northern on 12/13/2021.] |
| Oct 19, 2021 | 49 | Main Document (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Ty W. Callahan) by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 12/13/2021.] |
| Oct 19, 2021 | 49 | Proposed Order (1) |
| Oct 19, 2021 | 50 | Letter (12) Docket Text: COPY OF JPML HEARING ORDER re MDL No. 3017 re [16] Motion to Transfer. SECTION A (DESIGNATED FOR ORAL ARGUMENT). PANEL HEARING set for 12/2/2021 in Washington, DC. Notices of Presentation or Waiver of Oral Argument due on or before 11/8/2021. Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 10/18/2021. Associated Cases: MDL No. 3017, DE/1:21-cv-00314, DE/1:21-cv-00732, DE/1:21-cv-01000, DE/1:21-cv-01001, WVN/1:21-cv-00099. (dk)[Transferred from West Virginia Northern on 12/13/2021.] |
| Oct 13, 2021 | 48 | Order on Motion to Continue (2) Docket Text:ORDER GRANTING MOTION AND SCHEDULING STATUS CONFERENCE BY VIDEOCONFERENCE. The Motion [47] is GRANTED and the status conference is RESCHEDULED for 11/1/2021 12:00 PM in Judge Kleeh Chambers before District Judge Thomas S. Kleeh. Signed by District Judge Thomas S. Kleeh on 10/13/2021. (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Oct 12, 2021 | 46 | Answer to Complaint (17) Docket Text: ANSWER to [1] Complaint by Mylan Inc., Mylan Pharmaceuticals Inc..(Copland, Gordon) [Transferred from West Virginia Northern on 12/13/2021.] |
| Oct 12, 2021 | 47 | Main Document (4) Docket Text: MOTION to Continue Oct. 21, 2021 Status Conference by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit Exhibit A, # (2) Exhibit Exhibit B, # (3) Proposed Order)(Taylor, Chad)[Transferred from West Virginia Northern on 12/13/2021.] |
| Oct 12, 2021 | 47 | Exhibit Exhibit A (2) |
| Oct 12, 2021 | 47 | Exhibit Exhibit B (9) |
| Oct 12, 2021 | 47 | Proposed Order (1) |
| Sep 23, 2021 | 45 | Order (2) Docket Text:ORDER SCHEDULING STATUS CONFERENCE BY VIDEOCONFERENCE for 10/21/2021 11:00 AM before District Judge Thomas S. Kleeh. Signed by District Judge Thomas S. Kleeh on 9/23/21. (mh) [Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 15, 2021 | 44 | Order Reassigning Case (1) Docket Text:ORDER TRANSFERING CASE: The Court ORDERS that the above-styled civilaction be transferred to and placed on the docket of the HonorableThomas S. Kleeh, United States District Judge. Signed by Senior Judge Irene M. Keeley on 9/15/21. (jss)[Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 3, 2021 | 40 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting [33] Motion of Alexander S. Zolan for Leave to Appear Pro Hac Vice on behalf of Bayer Pharma AG, Bayer AG. Signed by Senior Judge Irene M. Keeley on 9/3/2021. (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 3, 2021 | 41 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting [35] Motion of Julie Tavares for Leave to Appear Pro Hac Vice on behalf of Bayer Pharma AG, Bayer AG. Signed by Senior Judge Irene M. Keeley on 9/3/2021. (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 3, 2021 | 42 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting [34] Motion of Kathryn S. Kayali for Leave to Appear Pro Hac Vice on behalf of Bayer AG, Bayer Pharma AG. Signed by Senior Judge Irene M. Keeley on 9/3/2021. (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 3, 2021 | 43 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting [36] Motion of Bruce R. Genderson for Leave to Appear Pro Hac Vice on behalf of Bayer AG, Bayer Pharma AG. Signed by Senior Judge Irene M. Keeley on 9/3/2021. (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 2, 2021 | 33 | Main Document (9) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Alexander Zolan by Bayer AG, Bayer Pharma AG. (Attachments: # (1) Proposed Order)(Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 2, 2021 | 33 | Proposed Order (1) |
| Sep 2, 2021 | 34 | Main Document (9) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Kathryn Kayali by Bayer AG, Bayer Pharma AG. (Attachments: # (1) Proposed Order)(Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 2, 2021 | 34 | Proposed Order (1) |
| Sep 2, 2021 | 35 | Main Document (9) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Julie Tavares by Bayer AG, Bayer Pharma AG. (Attachments: # (1) Proposed Order)(Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 2, 2021 | 35 | Proposed Order (1) |
| Sep 2, 2021 | 36 | Main Document (9) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Bruce Genderson by Bayer AG, Bayer Pharma AG. (Attachments: # (1) Proposed Order)(Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Sep 2, 2021 | 36 | Proposed Order (1) |
| Aug 30, 2021 | 31 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting [30] Motion of Andrew T. Langford for Leave to Appear Pro Hac Vice on behalf of Janssen Pharmaceuticals, Inc. Signed by Senior Judge Irene M. Keeley on 8/30/2021. (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 27, 2021 | 23 | Main Document (9) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Dov P. Grossman by Bayer AG, Bayer Pharma AG. (Attachments: # (1) Proposed Order)(Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 27, 2021 | 23 | Proposed Order (1) |
| Aug 27, 2021 | 25 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting [21] Motion for Elham Firouzi Steiner to Appear Pro Hac Vice on behalf of Mylan Inc. and Mylan Pharmaceuticals Inc. Signed by Senior Judge Irene M. Keeley on 8/27/2021. (dk)[Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 27, 2021 | 27 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting [22] Motion for Wendy L. Devine to Appear Pro Hac Vice on behalf of Mylan Inc. and Mylan Pharmaceuticals Inc. Signed by Senior Judge Irene M. Keeley on 8/27/2021. (dk)[Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 27, 2021 | 29 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting [23] Motion of Dov P. Grossman for Leave to Appear Pro Hac Vice on behalf of Bayer AG, Bayer Pharma AG. Signed by Senior Judge Irene M. Keeley on 8/27/2021. (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 27, 2021 | 30 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Andrew T. Langford by Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Proposed Order)(Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 27, 2021 | 30 | Proposed Order (1) |
| Aug 26, 2021 | 20 | Order on Motion to Substitute Attorney (2) Docket Text:ORDER GRANTING SUBSTITUTION OF LOCAL COUNSEL FOR PLAINTIFFS BAYER PHARMA AG AND BAYER AG: It is ORDERED that Steven Ruby and Raymond Franks are permitted to withdraw as counsel for Bayer and Frank Simmerman, Jr., Chad Taylor, and Frank Simmerman, III, are hereby substituted as counsel of record for Bayer. Attorney Raymond S Franks, II and Steven Robert Ruby terminated. Signed by Senior Judge Irene M. Keeley on 8/26/2021. (cnd) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 26, 2021 | 21 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hav Vice (Elham Firouzi Steiner) by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 26, 2021 | 21 | Proposed Order (1) |
| Aug 26, 2021 | 22 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hav Vice (Wendy L. Devine) by Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 26, 2021 | 22 | Proposed Order (1) |
| Aug 25, 2021 | 19 | Main Document (3) Docket Text: MOTION to Substitute Attorney Local Counsel by Bayer AG, Bayer Pharma AG. (Attachments: # (1) Proposed Order Proposed Order)(Ruby, Steven) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 25, 2021 | 19 | Proposed Order Proposed Order (2) |
| Aug 24, 2021 | 18 | Order (1) Docket Text:ORDER SCHEDULING STATUS CONFERENCE: The Court SCHEDULES a status conference by telephone for Friday, September 3, 2021, at 10:00 a.m. Signed by Senior Judge Irene M. Keeley on 8/24/21. (jss)[Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 23, 2021 | 17 | Motion to Seal (3) Docket Text:Request for Status Conference ( Other Document ) filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (O'Brien, William) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 16, 2021 | 12 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Mylan Pharmaceuticals Inc. on 8/12/21 by Janssen Pharmaceuticals, Inc.. Waiver of Service due by 9/13/2021. (Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 16, 2021 | 13 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Mylan Inc. on 8/12/21 by Janssen Pharmaceuticals, Inc.. Waiver of Service due by 9/13/2021. (Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 16, 2021 | 14 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by Janssen Pharmaceuticals, Inc.. Mylan Pharmaceuticals Inc. waiver sent on 8/12/2021, answer due 10/12/2021. (Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 16, 2021 | 15 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by Janssen Pharmaceuticals, Inc.. Mylan Inc. waiver sent on 8/12/2021, answer due 10/12/2021. (Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 16, 2021 | 16 | Main Document (6) Docket Text: Courtesy copy documents filed with the Judicial Panel on Multidistrict Litigation filed by Plaintiffs. (Attachments: # (1) Memorandum of Law in Support of Plaintiff's Motion for Transfer of Action to the District of Delaware, # (2) Schedule of Actions, # (3) Exhibit 1, # (4) Exhibit 2, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5, # (8) Proof of Service) (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 16, 2021 | 16 | Memorandum of Law in Support of Plaintiff's Motion for Transfer of Action (10) |
| Aug 16, 2021 | 16 | Schedule of Actions (3) |
| Aug 16, 2021 | 16 | Exhibit 1 (45) |
| Aug 16, 2021 | 16 | Exhibit 2 (43) |
| Aug 16, 2021 | 16 | Exhibit 3 (43) |
| Aug 16, 2021 | 16 | Exhibit 4 (43) |
| Aug 16, 2021 | 16 | Exhibit 5 (22) |
| Aug 16, 2021 | 16 | Proof of Service (6) |
| Aug 13, 2021 | 11 | Order (3) Docket Text:FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 10/22/2021. Rule 26 Meeting Report due by 11/5/2021. Scheduling Conference set for 11/19/2021 at 01:30 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Discovery due by 12/3/2021. Signed by Senior Judge Irene M. Keeley on 8/13/21. (jss) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 12, 2021 | 10 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Copland, Gordon) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 3, 2021 | 9 | Order on Motion to Appear Pro Hac Vice (1) Docket Text:ORDER granting Thomas D. Rein's [7] Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 8/3/21. (jss) [Transferred from West Virginia Northern on 12/13/2021.] |
| Aug 2, 2021 | 7 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Thomas D. Rein, by Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Proposed Order)(Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] Modified on 12/15/2021 (nms). |
| Aug 2, 2021 | 7 | Proposed Order (1) |
| Jul 23, 2021 | 5 | Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Janssen Pharmaceuticals, Inc. identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc... (Taylor, Chad) [Transferred from West Virginia Northern on 12/13/2021.] |
| Jul 22, 2021 | 1 | Main Document (12) Docket Text: COMPLAINT against Mylan Inc., Mylan Pharmaceuticals Inc., filed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Bayer AG. Filing Fee $402. Receipt #AWVNDC-3299654. (Attachments: # (1) Civil Cover Sheet) (dk)[Transferred from West Virginia Northern on 12/13/2021.] |
| Jul 22, 2021 | 1 | Civil Cover Sheet (3) |
| Jul 22, 2021 | 2 | Patent/Trademark Report to Commissioner (1) Docket Text: REPORT to United States Patent and Trademark Office. (dk) [Transferred from West Virginia Northern on 12/13/2021.] Modified on 12/15/2021 (nms). |
| Jul 22, 2021 | 3 | Summons Issued (4) Docket Text: SUMMONS ISSUED as to Mylan Inc., Mylan Pharmaceuticals Inc. (Original/copies returned to counsel for service) (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Jul 22, 2021 | 4 | Notice of Appearance (1) Docket Text: VERIFICATION OF ATTORNEY ADMISSION for Attorneys Bruce Genderson, Dov Grossman, Alexander Zolan, Kathryn Kayali, Julie Tavares, Thomas Rein. (dk) [Transferred from West Virginia Northern on 12/13/2021.] |
| Jul 22, 2021 | 6 | Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Bayer AG, Bayer Pharma AG. (wrr) [Transferred from West Virginia Northern on 12/13/2021.] |
